Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta

Journal of the American College of Cardiology

Volumn 29, Issue 4, 1997, Pages 800-807

  Hutchison, Stuart J ^a   Sudhir, Krishnankutty ^a   Chou, Tony M ^a   Sievers, Richard E ^a   Zhu, Bo Qing ^a   Sun, Yi Ping ^a   Deedwania, Prakash C ^a   Glantz, Stanton A ^a   Parmley, William W ^a   Chatterjee, Kanu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ESTRADIOL; GLYCERYL TRINITRATE; NORADRENALIN; PROGESTERONE; SEX HORMONE; TESTOSTERONE; TOBACCO SMOKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; AORTA; ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ESTRADIOL; HYPERCHOLESTEROLEMIA; MALE; PROGESTERONE; RABBITS; TESTOSTERONE; TOBACCO SMOKE POLLUTION; VASODILATION;

EID: 0030936503     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00570-0     Document Type: Article

References (58)

1. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 90:1992;1168-1172.
2. Wang BY, Singer AH, Tsao PS, Drexler H, Kosek J, Cooke JP. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J Am Coll Cardiol. 23:1994;452-458.
3. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 24:1994;1468-1474.
4. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans progressive endothelial dysfunction with different early stages of coronary atherosclerosis . Circulation. 83:1991;391-401.
5. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 23:1994;833-843.
6. Jacobs MC, Lenders JW, Kapma JA, Smits P, Thien T. Effect of chronic smoking on endothelium-dependent vascular relaxation in humans. Clin Sci. 85:1993;51-55.
7. Kiowski W, Linder L, Stoschitzky K, et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation. 90:1994;27-34.
8. Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 88:1993;2149-2155.
9. Hutchison S, Ibarra M, Chou T, et al. L-Arginine restores normal endothelium-mediated relaxation in hypercholesterolemic rabbits exposed to tobacco smoke [abstract]. J Am Coll Cardiol. 27:1996;Suppl A:39A.
10. Celermajer D, Adams M, Clarkson P, et al. Passive smoking is associated with impaired endothelium-dependent dilation in healthy young adults. N Engl J Med. 334:1996;150-154.
11. Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Glantz SA, Parmley WW. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol. 21:1993;225-232.
12. Sun YP, Zhu BQ, Sievers RE, Glantz SA, Parmley WW. Metoprolol does not attenuate atherosclerosis in lipid-fed rabbits exposed to environmental tobacco smoke. Circulation. 89:1994;2260-2265.
13. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RR. Acute vascular effects of estrogen in postmenopausal women. Circulation. 90:1994;786-791.
14. Ginsburg J, Hardiman P, O'Reilly B. Peripheral blood flow in menopausal women who have hot flushes and in those who do not. BMJ. 298:1989;1488-1490.
15. Shamma FN, Fayad P, Brass L, Sarrel P. Middle cerebral artery blood velocity during controlled ovarian hyperstimulation. Fertil Steril. 57:1992;1022-1025.
16. Penotti M, Nencioni T, Gabrielli L, Farina M, Castiglioni E, Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Am J Obstet Gynecol. 169:1993;1226-1232.
17. Adams MR, Williams JK, Clarkson TB, Jayo MJ. Effects of oestrogens and progestogens on coronary atherosclerosis and osteoporosis of monkeys. Baillieres Clin Obstet Gynaecol. 5:1991;915-934.
18. Sudhir K, Chou TM, Mullen WL, et al. Mechanisms of estrogen-induced vasodilation in vivo studies in canine coronary conductance and resistance arteries . J Am Coll Cardiol. 26:1995;807-814.
19. Mugge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro. Cardiovasc Res. 27:1993;1939-1942.
20. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 20:1992;452-457.
21. Williams JK, Honore EK, Washburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol. 24:1994;1757-1761.
22. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 81:1990;1680-1687.
23. Reis SE, Gloth ST, Blumenthal RS, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 89:1994;52-60.
24. Adams MR, Williams JK, Kaplan JR. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol. 15:1995;562-570.
25. Keaney JJ, Shwaery GT, Xu A, et al. 17-Beta-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 89:1994;2251-2259.
26. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits implications for atherosclerosis . Proc Natl Acad Sci USA. 89:1992;11259-11263.
27. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA. 91:1994;5212-5216.
28. Sudhir K, Jennings G, Funder J, Komesaroff P. Estrogen supplementation enhances basal release of nitric oxide in the forearm vasculature in perimenopausal women. Hypertension. 28:1996;300-304.
29. Nelson D, Kirkendall R, Lawton RL, et al. Surveillance for smoking-attributable mortality and years of life lost, by state - United States, 1990. MMWR. 43:1994;1-8.
30. Reducing the Health Consequences of Smoking - 25 years of Progress. 1989;117-169 U.S. Department of Health and Human Services, Rockville (MD).
31. Schatzkin A, Cupples LA, Heeren T, Morelock S, Kannel WB. Sudden death in the Framingham Heart Study differences in incidence and risk factors by sex and coronary disease status . Am J Epidemiol. 120:1984;888-899.
32. Steenland K, Thun M, Lally C, Heath C Jr. Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. Circulation. 94:1996;622-628.
33. Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Glantz SA, Parmley WW. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol. 21:1993;225-232.
34. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 90:1992;1168-1172.
35. Keaney JJ, Gaziano JM, Xu A, et al. Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest. 93:1994;844-851.
36. Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation. 81:1990;1586-1593.
37. Penn A, Snyder CA. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation. 90:1993;1820-1825.
38. 2 mimetic induced coronary artery vasoconstriction in guinea pigs. Eur J Clin Invest. 1:1994;50-52.
39. Greenberg S, George WR, Kadowitz PJ, Wilson WR. Androgen-induced enhancement of vascular reactivity. Can J Physiol Pharmacol. 52:1974;14-22.
40. 2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol. 267:1994;H887-93.
41. 2 receptors in cultured rat aortic smooth muscle cells. Circ Res. 69:1991;638-643.
42. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol. 261:1991;R1022-7.
43. Ross R. Factors influencing atherogenesis. Schlant R, Alexander R. Hurst's The Heart. vol 1:1994;998 McGraw-Hill, New York.
44. Klag MJ, Ford DE, Mead LA, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 328:1993;313-318.
45. Pekkanen J, Linn S, Heiss G, et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med. 322:1990;1700-1707.
46. Dobson AJ, Alexander HM, Heller RF, Lloyd DM. Passive smoking and the risk of heart attack or coronary death. Med J Aust. 154:1991;793-797.
47. He Y, Lam TH, Li LS, et al. Passive smoking at work as a risk factor for coronary heart disease in Chinese women who have never smoked. BMJ. 308:1994;380-384.
48. Hirayama T. Passive smoking - a new target of epidemiology. Tokai J Exp Clin Med. 10:1985;287-293.
49. Hole DJ, Gillis CR, Chopra C, Hawthorne VM. Passive smoking and cardiorespiratory health in a general population in the west of Scotland. BMJ. 299:1989;423-427.
50. Humble C, Croft J, Gerber A, Casper M, Hames CG, Tyroler HA. Passive smoking and 20-year cardiovascular disease mortality among nonsmoking wives, Evans County, Georgia. Am J Public Health. 80:1990;599-601.
51. Garland C, Barrett CE, Suarez L, Criqui MH, Wingard DL. Effects of passive smoking on ischemic heart disease mortality of nonsmokers a prospective study . Am J Epidemiol. 121:1985;645-650.
52. Helsing KJ, Sandler DP, Comstock GW, Chee E. Heart disease mortality in nonsmokers living with smokers. Am J Epidemiol. 127:1988;915-922.
53. Lee PN. Deaths from lung cancer and ischaemic heart disease due to passive smoking in New Zealand. N Z Med J. 102:1989;448.
54. Sandler DP, Comstock GW, Helsing KJ, Shore DL. Deaths from all causes in nonsmokers who lived with smokers. Am J Public Health. 79:1989;163-167.
55. Svendsen KH, Kuller LH, Martin MJ, Ockene JK. Effects of passive smoking in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 126:1987;783-795.
56. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol. 24:1994;546-554.
57. Gerhard M, Ganz P. How do we explain the clinical benefits of estrogen? From bedside to bench . Circulation. 92:1995;5-8.
58. Mills JL, Taylor LJ, Porter JM. Buerger's disease in the modern era. Am J Surg. 154:1987;123-129.